* Sumitomo dainippon pharma says u.s. Unit agrees to buy
cynapsus therapeutics for about $624 million
Source text for Eikon:
Further company coverage: [ ]
The post BRIEF-Sumitomo dainippon pharma says u.s. Unit agrees to buy cynapsus therapeutics for about $624 million appeared first on NASDAQ.